REGENXBIO
REGENX Biosciences is a biopharmaceutical company that develops therapeutics and research tools based on adeno-associated viral (AAV) vectors. The company offers NAV, a gene delivery technology that includes recombinant adeno-associated viral vectors. Its technology is used for the treatment of metabolic disorders, muscle diseases, hematologic disorders, ocular diseases, and neurodegenerative disorders; and clinical trails in therapeutic areas, such as inherited diseases, CNS disorders, heart fa... ilure, and vaccines. The company also offers reagent services for various applications, including molecular therapies, understanding biological activity, and target validation, creating disease models and screening in vivo, and genome-wide association studies. In addition, it offers custom products and services, including AAV plasmids, AAV Vector reporter systems, and custom AAV vectors to the researchers. The company is based in Washington, District Of Columbia.
REGENXBIO
Industry:
Biopharma Biotechnology Genetics Therapeutics
Founded:
2009-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.regenxbio.com
Total Employee:
251+
Status:
Active
Contact:
(202) 785-7438
Email Addresses:
[email protected]
Total Funding:
638.19 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-08-25 | Dimension Therapeutics | Dimension Therapeutics acquired by REGENXBIO | N/A |
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - REGENXBIO
RTW Investments LLC
RTW Investments LLC investment in Series D - REGENXBIO
Foresite Capital
Foresite Capital investment in Series D - REGENXBIO
Perceptive Advisors
Perceptive Advisors investment in Series D - REGENXBIO
Sectoral Asset Management
Sectoral Asset Management investment in Series D - REGENXBIO
Venrock
Venrock investment in Series D - REGENXBIO
Cormorant Asset Management
Cormorant Asset Management investment in Series D - REGENXBIO
QVT Financial
QVT Financial investment in Series D - REGENXBIO
F-Prime Capital
F-Prime Capital investment in Series D - REGENXBIO
Tourbillon Global Ventures
Tourbillon Global Ventures investment in Series D - REGENXBIO
Official Site Inspections
http://www.regenxbio.com Semrush global rank: 1.53 M Semrush visits lastest month: 17.31 K
- Host name: 20.231.205.235
- IP address: 20.231.205.235
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
